个人简介
教育背景
2004.9-2008.7 天津医科大学 免疫学 博士
1999.9-2002.7 天津医科大学 临床检验诊断学 硕士
1994.9-1999.7 天津医科大学 医学检验 学士
工作经历
2013/11-至今,副教授,基础医学院免疫学系,天津医科大学
2008/09-2010/12,博士后,Keller实验室,密西根大学,美国
2006/01-2008/05,访问学者,Keller实验室,密西根大学,美国
2005/02-2005/07,访问学者,留学基金委高校基础课青年教师英文教学培训项目,曼彻斯特大学,英国
2004/11-2013/11,讲师,基础医学院免疫学系,天津医科大学
2002/09-2004/11,助教,基础医学院免疫学系,天津医科大学
荣誉奖励
长效人重组白细胞介素-6的研制。天津市科技进步奖二等奖,2003年,第五完成人
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
1.The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases. Int Rev Immunol. Chen Y, Yu CY, Deng WM. 2019 Jul 28:1-18. doi: 0.1080/08830185.2019.1645138 (IF 3.481)
2. Zhi L, Gao Y, Yu C# , Zhang Y, Zhang B, Yang J, Yao Z. N-Cadherin Aided in Maintaining the Characteristics of Leukemic Stem Cells.Anat Rec (Hoboken). 2016 Jul;299(7):990-8. doi: 10.1002/ar.23345.(共同第一作者)(IF:1.431)
3. Zhang H#, Yu C#, Dai J, Keller JM, Hua A, Sottnik JL, Shelley G, Hall CL, Park SI, Yao Z, Zhang J, McCauley LK, Keller ET*. Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer. Oncogene. 2014, 33(19):2464-77(共同第一作者) (IF:7.357)
4. Yu C#,Yao Z, Dai J, Zhang H, Escara-Wilke J, Zhang X, Keller ET*. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines. In Vivo. 2011 Jan-Feb;25(1): 69-76. (IF: 1.264)
5. Yu C#, Shiozawa Y, Taichman RS, McCauley LK, Pienta K, Keller E*. Crit Rev Eukaryot Gene Expr. 2012;22 (2):131-48.Prostate cancer and parasitism of the bone hematopoietic stem cell niche. (IF: 3.075)
6. Yu C#, Yao Z, Jiang Y, Keller ET. Minerva Urol Nefrol. 2012 Mar;64(1) :19-33. Prostate cancer stem cell biology.(IF: 0.634)
7.Dai J, Lu Y, Yu C, Keller JM, Mizokami A, Zhang J, Keller ET*.Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony- stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors. Cancer Res.2010 Jun 15;70(12):5014-23. (IF: 7.543)
8. Comstock KE, HallCL, Daignault S, Mandlebaum SA,Yu C, Keller ET*. In Vivo. 2009 Sep-Oct;23(5):661-8. A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo. (IF: 1.171)